Association of chronic fatigue syndrome with human leucocyte antigen class II alleles

Journal of Clinical Pathology

Volumn 58, Issue 8, 2005, Pages 860-863

  Smith, J ^c   Fritz, E L ^b   Kerr, J R ^a   Cleare, A J ^d   Wessely, S ^d   Mattey, D L ^e  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c HAREFIELD HOSPITAL   (United Kingdom)

^d SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UNITED KINGDOM;

ADULT; ALLELES; FATIGUE SYNDROME, CHRONIC; FEMALE; GENE FREQUENCY; GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED;

EID: 23444460688     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.022681     Document Type: Article

References (35)

1. Evengard B, Klimas N. Chronic fatigue syndrome: probable pathogenesis and possible treatments. Drugs 2002;62:2433-46.
2. Buchwald D, Umali P, Umali J, et al. Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific northwest health care system. Ann Intern Med 1995;123:81-8.
3. Georgiades E, Behan W, Kilduff L, et al. Chronic fatigue syndrome: new evidence for a central fatigue disorder. Clin Sci (Lond) 2003;105:213-18.
4. Fukuda K, Straus S, Hickie I, and The International Chronic Fatigue Syndrome Study Group, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994;121:953-9.
5. Chia J, Chia A. Diverse etiologies for chronic fatigue syndrome. Clin Infect Dis 2003;36:671-2.
6. Kerr J, Barah T, Mattey D, et al. Circulating tumour necrosis factor-α and interferon-γ are detected during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue. J Gen Virol 2001;82:3011-19.
7. Keller R, Lane J, Klimas N, et al. Association between HLA class II antigens and the chronic fatigue immune dysfunction. Clin Infect Dis 1994;18(suppl 1):S154-6.
8. Hassan I, Bannister B, Akbar A, et al. A study of the immunology of the chronic fatigue syndrome: correlation of immunologic parameters to the health dysfunction. Clin Immunol Immunopathol 1998;87:60-7.
9. Patarca R. Cytokines and chronic fatigue syndrome. Ann NY Acad Sci 2001;993:185-200.
10. Patarca-Montero R, Klimas N, Fletcher M. Immunotherapy of chronic fatigue syndrome: therapeutic interventions aimed at modulating the Th1/Th2 cytokine expression balance. J Chronic Fatigue Syndr 2001;8:3-37.
11. Fletcher M, Maher K, Klimas N. Natural killer cell function in chronic fatigue syndrome. Clinical and Applied Immunology Reviews 2002;2:129-39.
12. Natelson BH, La Manca JJ, Denny TH, et al. Immunologic parameters in chronic fatigue syndrome, major depression, and multiple sclerosis. Am J Med 1998;105:435-95.
13. Lyall M, Wessely S, Peakman M. A systematic review and critical evaluation of the immunology of chronic fatigue syndrome. J Psychosom Res 2003;55:79-90.
14. Hickie IB, Bansal AS, Kirk KM, et al. A twin study of the etiology of prolonged fatigue and immune activation. Twin Res 2001;4:94-102.
15. Buchwald D, Herell R, Ashton S, et al. A twin study of chronic fatigue. Psychosom Med 2001;63:936-43.
16. Koelle DM, Barcy S, Huang ML, et al. Markers of viral infection in monozygotic twins discordant for chronic fatigue syndrome. Clin Infect Dis 2002;35:518-25.
17. Sabath DE, Barcy S, Koelle DM, et al. Cellular immunity in monozygotic twins discordant for chronic fatigue syndrome. J Infect Dis 2002;185:828-32.
18. Middleton D, Savage D, Smith D. No association of HLA class II antigens in chronic fatigue syndrome. Dis Markers 1991;9:47-9.
19. Underbill JA, Mahalingam M, Peakman M, et al. Lack of association between HLA genotype and chronic fatigue syndrome. Eur J Immunogenet 2001;28:425-8.
20. Fitzgibbon E, Whelto H, Smith T. HLA DR class II antigens and post viral fatigue syndrome [abstract]. J Chronic Fatigue Syndr 1996;2:166.
21. Logean A, Rognan D. Recovery of known T-cell epitopes by computational scanning of a viral genome. J Comput Aided Mol Des 2002;16:229-43.
22. Vukmanović S, Neubert T, Santori F. Could TCR antagonism explain associations between MHC genes and disease? Trends Mol Med 2003;9:139-40.
23. Vollmer-Conna U, Lloyd A, Hickie I, et al. Chronic fatigue syndrome: an immunological perspective. Aust N Z J Psychiatry 1998;32:523.
24. Nachum F. Is interferon-α a neuromodulator? Brain Res Rev 1998;26:1-15.
25. Kerr J, Mattey D, Thomson W, et al. Association of symptomatic acute parvovirus B19 infection with human leukocyte antigen class I and II alleles. J Infect Dis 2002;186:447-52.
26. Sharpe M, Chalder T, Palmer I, et al. Chronic fatigue syndrome. A practical guide to assessment and management. Gen Hosp Psychiatry 1997;19:185-99.
27. Whiteside T, Friberg D. Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am J Med 1998;105(3A):27S-34S.
28. Karell K, Louka A, Moodie S, et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European genetics cluster on celiac disease. Hum Immunol 2003;64:469-77.
29. Heward J, Mijovic C, Kelly M, et al. HLA-DQ and DRB1 polymorphism and susceptibility to type 1 diabetes in Jamaica. Eur J Immunogenet 2002;29:47-52.
30. Levinson RD, Park MS, Rikkers SM, et al. Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci 2003;44:653-7.
31. Hayney MS, Poland GA, Jacobson RM, et al. Relationship of HLA-DQA1 alleles and humoral antibody following measles vaccination. Inf J Infect Dis 1998;2:143-6.
32. Casamitjana N, Gil J, Campos E, et al. Identification of a novel HLA-DQB1*06 allele, DQB10*618. Tissue Antigens 2001;58:269-71.
33. Chabas D, Taheri S, Renier C, et al. The genetics of narcolepsy. Annu Rev Genomics Hum Genet 2003;4:459-83.
34. Giordano M, D'Alfonso S, Momigliano-Richiardi P. Genetics of multiple sclerosis: linkage and association studies. Am J Pharmacogenomics 2002;2:37-58.
35. Ambrogetti A, Olson LG. Consideration of narcolepsy in the differential diagnosis of chronic fatigue syndrome. Med J Aust 1994;160:426-9.